Senior insider sale
SVP, Chief Medical Officer at REATA PHARMACEUTICALS INC — senior position signals high conviction
$114.6K
679.00 shares
What this filing means
KHAN SAMINA plans to sell 679.00 shares of REATA PHARMACEUTICALS INC valued at approximately $114.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/5/2023ACC: 0001964306-23-000205
Officer· SVP, Chief Medical Officer
Since Feb 2022
679.00
Shares to sell
$114.6K
Approx. market value
343.00
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
9/1/2023
343.00Total acquired343.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2023 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 343.00 | — |
| Total | 343.00 | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
336.00
Market value
$56.6K
8/16/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
343.00
Market value
$58.0K
9/5/2023
Total
Units
679.00
Value
$114.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/16/2023 | 336.00 | $56.6K | — | Completed |
| Planned — Approximate Date | ||||
9/5/2023 | 343.00 | $58.0K | NASDAQ | Planned |
| Total | 679.00 | $114.6K | ||